We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need.
52 Week High
52 Week Low
Data Provided by Refinitiv. Minimum 15 minutes delayed.